Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05C HYPNOTICS AND SEDATIVES
N05CM Other hypnotics and sedatives
N05CM18 Dexmedetomidine
D01205 Dexmedetomidine hydrochloride (JAN/USP) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
112 Hypnotics and sedatives, anxiolytics
1129 Others
D01205 Dexmedetomidine hydrochloride (JAN/USP)
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01450 alpha-Adrenergic receptor agonist
DG01449 alpha2-Adrenergic receptor agonist
DG00926 Dexmedetomidine
D01205 Dexmedetomidine hydrochloride
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
DG00926 Dexmedetomidine
D01205 Dexmedetomidine hydrochloride
DG01638 CYP2A6 substrate
DG00926 Dexmedetomidine
D01205 Dexmedetomidine hydrochloride
DG01639 CYP2C19 substrate
DG00926 Dexmedetomidine
D01205 Dexmedetomidine hydrochloride
DG01644 CYP2D6 substrate
DG00926 Dexmedetomidine
D01205 Dexmedetomidine hydrochloride
DG02855 CYP2E1 substrate
DG00926 Dexmedetomidine
D01205 Dexmedetomidine hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRA2
D01205 Dexmedetomidine hydrochloride (JAN/USP) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D01205
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D01205
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D01205
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01205
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D01205
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01450 alpha-Adrenergic receptor agonist
DG01449 alpha2-Adrenergic receptor agonist
DG00926 Dexmedetomidine
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
DG00926 Dexmedetomidine
DG01638 CYP2A6 substrate
DG00926 Dexmedetomidine
DG01639 CYP2C19 substrate
DG00926 Dexmedetomidine
DG01644 CYP2D6 substrate
DG00926 Dexmedetomidine
DG02855 CYP2E1 substrate
DG00926 Dexmedetomidine